Navigation » List of Schools » International College of Health Sciences » Nursing » Nursing 1141- Pharmacology » Fall 2022 » Mastery EAQ Ch. 34
Below are the questions for the exam with the choices of answers:
Question #1
A Decreased pain
B Strong contractions
C Softened cervix
D Midline fundus
Question #2
A Abnormal vaginal bleeding
B Renal failure
C Ovarian failure
D Pulmonary embolism
Question #3
A Blurred vision, Bradycardia, Increased diuresis
B Anxiety, Dizziness, Blurred vision
C Hirsutism, Dizziness,, Increased diuresis
D Hirsutism, Bradycardia, Increased diuresis
Question #4
A During the entire period the patient is taking the antibiotic
B For at least 1 month after starting the antibiotic
C Until three throat cultures have been negative for the pathogen
D For at least 6 weeks, starting at the end of the antibiotic regimen
Question #5
A Estradiol
B Megestrol
C Methylergonovine
D Alendronate
Question #6
A Protamine sulfate
B Calcium gluconate
C Atropine
D Epinephrine
Question #7
A Request a prescription to give calcium gluconate.
B Obtain a prescription for indomethacin.
C Obtain a prescription for terbutaline.
D Decrease the drug dose immediately.
Question #8
A Immediately discontinue intravenous (IV) fluids.
B Administer phentolamine mesylate.
C Place the patient on her left side.
D Instruct the patient to bear down and push.
Question #9
A Administer it before placenta delivery. Monitor blood pressure during administration. Assess for pelvic inflammatory disease. Question the prescription if the patient has liver disease.
B Monitor the patient for blurred vision. Administer it before placenta delivery. Assess for pelvic inflammatory disease. Question the prescription if the patient has liver disease.
C Monitor the patient for blurred vision. Monitor blood pressure during administration. Assess for pelvic inflammatory disease. Question the prescription if the patient has liver disease.
D Monitor the patient for blurred vision. Monitor blood pressure during administration. Administer it before placenta delivery. Question the prescription if the patient has liver disease.
Question #10
A Nausea and vomiting
B Uterine atony
C Hypertension
D Pelvic inflammatory disease
Question #11
A Uterine contractions
B Blood glucose
C Blood pressure
D Temperature
Question #12
A Ineffective contractions in a full-term pregnancy
B Radiographic confirmation of cephalopelvic disproportion
C Vaginal bleeding at 38 weeks’ gestation
D Absence of cervical ripening at 42 weeks’ gestation
Question #13
A Low fluid intake
B Cigarette use
C Current tricyclic antidepressant use
D Use of herbal supplements
Question #14
A The patient’s blood pressure and pulse, Complete blood cell count, Uterine hyperactivity
B Fetal heart rate, Fetal movement, The patient’s blood pressure and pulse
C Fetal movement, Uterine hyperactivity, Complete blood cell count
D Uterine hyperactivity, Fetal heart rate, Complete blood cell count
Question #15
A Calcitonin
B Ibandronate
C Denosumab
D Tamoxifen
Question #16
A Persuade the patient to start the therapy.
B Advise the patient to engage in quiet activities.
C Ask the patient to include soy in her diet.
D Inform the patient about the benefits and risks of the therapy.
Question #17
A “The treatment should be started as soon as possible.”
B “The treatment is likely to cause endometrial cancer.”
C “You may need to stop smoking during the therapy.”
D “The therapy may cause thromboembolic events.”
Question #18
A Ritodrine
B Terbutaline
C Bed rest and hydration
D Magnesium sulfate
Question #19
A Antibiotic therapy
B Hypertension
C Anticonvulsant therapy
D Diabetes
Question #20
A Male condom with spermicidal jelly
B Norethindrone and ethinyl estradiol
C Medroxyprogesterone
D Cervical cap with spermicidal jelly
Question #21
A Current smoker
B Joint pain
C Breast cancer
D Allergy to salmon
Question #22
A “Discontinue the calcium supplement.”
B “Obtain a prescription for increasing the bisphosphonate dose.”
C “Space the medications 1 to 2 hours apart.”
D “Replace the bisphosphonate with calcitonin.”
Question #23
A “Perform weight-bearing exercise.”
B “Report missed menstrual periods.”
C “Have tests for serum cholesterol.”
D “Have a yearly mammogram.”
Question #24
A “High progesterone levels inhibit the release of luteinizing hormone.”
B “Estrogen levels inhibit the release of follicle-stimulating hormone.”
C “Surges of Gn-RH, follicle-stimulating hormone, and luteinizing hormone stimulate ovulation.”
D “Decreased Gn-RH suppresses the release of follicle-stimulating hormone.”
Question #25
A “I have seen a great improvement in my sexual desire.”
B “I no longer experience hot flashes.”
C “I have not experienced any uterine bleeding.”
D “I am no longer experiencing painful intercourse.”
Question #26
A Metformin
B Amoxicillin
C Ferritin
D Levothyroxine
Question #27
A Contains estrogen, which stimulates bone reabsorption
B Promotes bone absorption of calcium
C Inhibits osteoclast-mediated bone reabsorption
D Stimulates estrogen receptors on the bone to increase bone density
Question #28
A Levothyroxine, Multivitamin
B Atenolol, Levothyroxine
C Warfarin, Cholestyramine
D Multivitamin, Atenolol
Question #29
A “This medication will help relieve the bone pain I have from my osteoporosis.”
B “I need to take this medication with food to prevent damage to my esophagus.”
C “I need to decrease my intake of dairy products to prevent hypercalcemia.”
D “I will take the medication on an empty stomach and not lie down for 30 minutes.”
Question #30
A Chest pain, Hot flashes, Loss of appetite
B Hot flashes, Loss of appetite, Joint pain
C Vertigo, Joint pain, Chest pain
D Hot flashes, Vertigo, Loss of appetite
Question #31
A To terminate pregnancy
B To treat pelvic inflammatory disease
C To induce cervical ripening
D To treat gestational hypertension
Question #32
A Increased body mass index (BMI)
B Smoking heavily every day
C Consumption of saturated fats
D Sedentary lifestyle
Question #33
A Monotherapy with a progestin increases breast cancer risk.
B Estradiol with progestin increases the risk of endometrial cancer.
C Estrogen monotherapy increases the risk of breast cancer.
D Unopposed estrogen increases the risk of endometrial cancer.
Question #34
A Terbutaline
B Oxytocin
C Clomiphene
D Prostaglandin E
Question #35
A Megestrol
B Medroxyprogesterone
C Estropipate
D Estrone
Question #36
A Loss of hair
B Brown discoloration of face
C Yellow undertone to the skin
D Hot flashes
Question #37
A Monitor the patient’s blood pressure frequently.
B Administer acetaminophen as needed.
C Assess pulse oximetry continuously.
D Suggest the patient take aluminum hydroxide with the medication.
Question #38
A Dinoprostone
B Indomethacin
C Clomiphene
D Oxytocin
Question #39
A Clomiphene
B Progesterone
C Choriogonadotropin alfa
D Ethinyl estradiol
Question #40
A Uterine bleeding
B Weight loss
C Deep vein thrombosis
D Dysmenorrhea
Question #41
A “Vaginal cancer is prevented by adding progestin to the regimen.”
B “Endometrial cancer risk can be reduced by adding progestin.”
C “The progestin in the regimen will help prevent ovarian cancer.”
D “The progestin in the regimen will help prevent breast cancer.”
Question #42
A Diminished endometrial tissue proliferation
B Interference with the proliferation of the fertilized ovum
C Elevated progesterone levels inhibiting the release of the luteinizing hormone
D Inhibition of the release of gonadotropins
Question #43
A Follicle-stimulating hormone
B Antidiuretic hormone
C Adrenocorticotropic hormone
D Luteinizing hormone
Question #44
A Thrombophlebitis
B Dysmenorrhea
C Hypertension
D Weight gain
Question #45
A Dry skin
B Nausea
C Higher-pitched voice
D Weight loss
Question #46
A Postpartum hemorrhage
B Termination of pregnancy
C Accelerated labor
D Premature labor
Question #47
A Esterified estrogens
B Alendronate
C Medroxyprogesterone
D Megestrol
Question #48
A Phase 3
B Phase 1
C Phase 2
D Phase 4
Question #49
A Extended-cycle
B Biphasic
C Triphasic
D Monophasic
Question #50
A Follicle-stimulating hormone (FSH)
B Luteotropic hormone
C Luteinizing hormone (LH)
D Interstitial cell-stimulating hormone
Question #51
A Megestrol
B Methylergonovine
C Medroxyprogesterone acetate
D Indomethacin
Question #52
A Methylergonovine
B Oxytocin
C Magnesium sulfate
D Terbutaline
Question #53
A Megestrol
B Methylergonovine
C Raloxifene
D Clomiphene
Question #54
A Day 7
B Day 21
C Day 14
D Day 3
Question #55
A Antidiuretic hormone
B Follicle-stimulating hormone (FSH)
C Luteinizing hormone (LH)
D Adrenocorticotropic hormone
Question #56
A The patient’s blood pressure is stable.
B The patient is ready for delivery.
C The contractions can be fatal to the patient.
D The fetal heart rate is stable.
Question #57
A Current smoking status
B Current use of medications for depression
C Compliance with the fertility drugs
D Presence of abnormal uterine bleeding
Question #58
A Dementia, Ovarian cancer, Cigarette smoking, Cardiovascular disease, Serious cardiovascular events
B Dementia, Breast cancer, Ovarian cancer, Cardiovascular disease, Serious cardiovascular events
C Dementia, Breast cancer, Cigarette smoking, Cardiovascular disease, Ovarian cancer
D Dementia, Breast cancer, Cigarette smoking, Cardiovascular disease, Serious cardiovascular events